Eliminating cervical cancer: progress and challenges for high-income countries

JC Davies-Oliveira, MA Smith, S Grover, K Canfell… - Clinical Oncology, 2021 - Elsevier
Abstract In 2020, the World Health Organization launched a major initiative to eliminate
cervical cancer globally. The initiative is built around the three key pillars of human …

An overview of cervical cancer epidemiology and prevention in the Baltic States

U Kojalo, A Tisler, K Parna, A Kivite-Urtane, J Zodzika… - BMC Public Health, 2023 - Springer
Abstract Aims To inform future Baltic States-specific policy analyses, we aimed to provide an
overview of cervical cancer epidemiology and existing prevention efforts in Estonia, Latvia …

Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an …

MA Smith, EA Burger, A Castanon, IMCM de Kok… - Preventive …, 2021 - Elsevier
COVID-19 has disrupted cervical screening in several countries, due to a range of policy-,
health-service and participant-related factors. Using three well-established models of …

Strategies to eliminate cervical cancer in China

L Ji, M Chen, L Yao - Frontiers in Oncology, 2023 - frontiersin.org
Cervical cancer is a widely distributed disease that is preventable and controllable through
early intervention. The World Health Organization has identified three key measures …

Rapid elimination of cervical cancer while maintaining the harms and benefits ratio of cervical cancer screening: a modelling study

EEL Jansen, IMCM de Kok, S Kaljouw, E Demirel… - BMC medicine, 2022 - Springer
Background Human papillomavirus (HPV) vaccination and intensifying screening expedite
cervical cancer (CC) elimination, yet also deteriorate the balance between harms and …

Public health impact and cost-effectiveness of switching from bivalent to nonavalent vaccine for human papillomavirus in Norway: incorporating the full health impact …

I Diakite, S Nguyen, U Sabale, A Pavelyev… - Journal of Medical …, 2023 - Taylor & Francis
Aim The objective of this study was to estimate and compare the cost-effectiveness of
switching from a bivalent to a nonavalent human papillomavirus (HPV) vaccination program …

Switching clinic‐based cervical cancer screening programs to human papillomavirus self‐sampling: A cost‐effectiveness analysis of vaccinated and unvaccinated …

K Pedersen, A Portnoy, S Sy, BT Hansen… - … Journal of Cancer, 2022 - Wiley Online Library
Several countries have implemented primary human papillomavirus (HPV) testing for
cervical cancer screening. HPV testing enables home‐based, self‐collected sampling (self …

Strategies to accelerate the elimination of cervical cancer in British Columbia, Canada: a modelling study

RE Pataky, S Izadi-Najafabadi, LW Smith, A Gottschlich… - CMAJ, 2024 - Can Med Assoc
Background: To eliminate cervical cancer in Canada by 2040, defined as an annual age-
standardized incidence rate (ASIR) lower than 4.0 per 100 000 women, the Canadian …

Vaccination and screening strategies to accelerate cervical cancer elimination in Norway: a model-based analysis

A Portnoy, K Pedersen, JJ Kim, EA Burger - British Journal of Cancer, 2024 - nature.com
Background Experts have proposed an 'EVEN FASTER'concept targeting age-groups
maintaining circulation of human papillomavirus (HPV). We explored effects of the …

Accounting for adverse events following immunization in economic evaluation: systematic review of economic evaluations of pediatric vaccines against …

K Doggen, AJ van Hoek, J Luyten - PharmacoEconomics, 2023 - Springer
Objectives Economic evaluations of vaccines should accurately represent all relevant
economic and health consequences of vaccination, including losses due to adverse events …